Bionano Genomics, Inc. (BNGO) [Rocket]

In millions, except per share items	Jun-30-23	Mar-31-23	Dec-31-22	Jun-30-22	Mar-31-22	Dec-31-21	Sep-30-21	Jun-30-21
	10-Q	10-Q	8-K	10-Q	10-Q	10-K	10-Q	10-Q
Revenue:
Total revenue				23.3	20.5	18.0	15.7	13.2
Total revenue growth				76.6%	94.7%	111.4%	114.6%	56.9%
Operating expenses:
Total cost of revenue				19.6	16.8	14.1	10.9	8.8

Operating expenses:
Research and development				38.0	30.3	22.5	16.1	11.9
Selling, general and administrative				77.2	69.2	58.5	48.1	41.4
Total operating expenses				250.0	216.0	176.1	139.4	115.6
Loss from operations				-111.5	-95.9	-77.1	-59.4	-49.0
Operating margin				-478.0%	-467.5%	-428.8%	-379.4%	-370.9%

Other income (expense):
Interest income				0.4	0.0	-0.7	-1.3	-1.9
Interest expense				-0.4	-0.6	-1.1		-2.1
Other income (expense)				-0.2	-0.1	-0.1	-0.1	0.0
Total other income (expense)				-0.3	-2.4	-1.1	-1.8	-2.2
Loss before income taxes				-111.5	-98.2	-78.2	-61.2	-51.2
Benefit (provision) for income taxes				5.7	5.7	5.7	0.0	0.0
Net loss				-105.8	-92.4	-72.4	-61.2	-51.3

Net loss per share, basic (in dollars per share)				($1.39)	($0.33)	($0.26)	($0.23)	($0.24)
Net loss per share, diluted (in dollars per share)				($1.39)	($0.33)	($0.26)	($0.23)	($0.24)

Weighted-average common shares outstanding, basic (in shares)				217.5	280.1	274.9	231.8	195.0
Weighted-average common shares outstanding, diluted (in shares)				217.5	280.1	274.9	231.8	195.0